CRD-A 8-K
Crawford & Co (CRD-A)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities Registered Pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01. Other Events.
On October 30, 2025, Crawford & Company (the “Company”) issued a press release announcing that its Board of Directors authorized the Company to increase its current share repurchase program, approved November 4, 2021, by an additional two million shares of its common stock and extend the program’s termination date to December 31, 2027. Under the share repurchase program initially established by the Board on November 4, 2021, and added to on February 10, 2022, the Company was authorized to repurchase up to an aggregate of seven million shares of its common stock. As of October 30, 2025, there were 634,920 shares of common stock remaining unexercised under the share repurchase program. Additionally, on October 30, 2025, the Board of Directors approved a quarterly cash dividend of $0.075 per share for both the Class A and Class B common stock, payable on December 5, 2025, to shareholders of record as of November 19, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
Item 9.01. Financial Statements and Exhibits.
| (a) | Exhibits. The following exhibit is filed with this Report: |
|
Exhibit No. |
Description | ||
| 99.1 | Press Release dated November 3, 2025 | ||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CRAWFORD & COMPANY | ||
| By: | /s/ Tami E. Stevenson | |
| Name: Tami E. Stevenson | ||
| Title: SVP, General Counsel and Corporate Secretary | ||
Date: November 3, 2025
-3-
Exhibit 99.1
 |
 |
Crawford & Company®
5335 Triangle Parkway NW
Peachtree Corners, GA 30092
|
FOR IMMEDIATE RELEASE |
CRAWFORD & COMPANY BOARD DECLARES QUARTERLY DIVIDENDS
AND AUTHORIZES ADDITIONAL SHARE REPURCHASE
ATLANTA (November 3, 2025) On October 30, 2025, at its regular quarterly meeting, the Board of Directors of Crawford & Company® (NYSE: CRD-A and CRD-B) authorized an increase to the Company’s share purchase program, approved on November 4, 2021, by an additional two million shares of its common stock. It also extended the termination date of the program to December 31, 2027. Under the share repurchase program initially established by the Board on November 4, 2021, and added to on February 10, 2022, the Company was authorized to repurchase up to an aggregate of seven million shares of its common stock. As of October 30, 2025, there were only 634,920 shares of common stock remaining.
Under this repurchase program, repurchases may be made in the open market or privately negotiated transactions, at such times and for such prices as management deems appropriate, subject to applicable regulatory guidelines. The new authorization does not obligate Crawford to acquire any stock, and purchases may be commenced or suspended at any time based on market conditions and other factors that the company deems appropriate.
“Given our solid revenue growth, progress against our strategy and our current share price, which we believe is trading below intrinsic value, we are pleased with our Board’s authorization of an additional two million shares for repurchase,” said Rohit Verma, Crawford chief executive officer.
The Board also declared a quarterly dividend of $0.075 per share on both Class A and Class B Common Stock. The dividend is payable on December 5, 2025, to shareholders of record as of the close of business on November 19, 2025.
|
|
Crawford & Company®
5335 Triangle Parkway NW
Peachtree Corners, GA 30092
About Crawford®
Based in Atlanta, Crawford & Company (NYSE: CRD-A and CRD-B) is a leading global provider of claims management and outsourcing solutions to insurance companies and self-insured entities with an expansive network serving clients in more than 70 countries. The Company’s two classes of stock are substantially identical, except with respect to voting rights for the Class B Common Stock (CRD-B) and protections for the non-voting Class A Common Stock (CRD-A). More information is available at www.crawco.com.
Tag: Crawford-Investor-News-and-Events, Crawford-Financial
# # #
Media Contacts: [email protected]
| Lynn Cufley | Katie Cline |
| +44 207 265 4067 | +1 470 792 5678 |
| [email protected] | [email protected] |